Methamphetamine (METH) is a powerful psychostimulant that is increasingly a
bused worldwide. Although it is commonly accepted that the dopaminergic sys
tem and oxidation of dopamine (DA) play pivotal roles in the neurotoxicity
produced by this phenylethylamine, the primary source of DA responsible for
this effect has remained elusive. In this study, we used mice heterozygous
for vesicular monoamine transporter 2 (VMAT2 +/- mice) to determine whethe
r impaired vesicular function alters the effects of METH. METH-induced dopa
minergic neurotoxicity was increased in striatum of VMAT2 +/- mice compared
with wild-type mice as revealed by a more consistent DA and metabolite dep
letion and a greater decrease in dopamine transporter expression. Interesti
ngly, increased METH neurotoxicity in VMAT2 +/- mice was accompanied by les
s pronounced increase in extracellular DA and indices of free radical forma
tion compared with wild-type mice. These results indicate that disruption o
f vesicular monoamine transport potentiates METH-induced neurotoxicity in v
ivo and point, albeit indirectly, to a greater contribution of intraneurona
l DA redistribution rather than extraneuronal overflow on mediating this ef
fect.